is the fda going to ban semaglutide Despite ruling, compounded GLP-1s are still giving Novo and Lilly headaches on market Compounded Semaglutide Ban: Current Status

Cons of GLP-1 Medications With so many promising effects from these injections, why wouldnt everyone want to use them

Safety, Side Effects, and What to Expect During GLP-1 Treatment Common early side effects of GLP-1 therapy include mild nausea, reduced appetite, and occasional gastrointestinal changesmost resolve within 1-2 weeks as your body adjusts

Graham Thoms, chief executive of Pharmadoctor, which provides clinical services and support to independent pharmacies, said: In addition to putting additional pressure on the Mounjaro supply chain, which can lead to shortages, it is simply not clinically appropriate to provide patients with multiple pens of Mounjaro at one time, and could put patients health at risk. Pharmadoctor partner pharmacies should make sure each patient has a face-to-face consultation every four weeks before they can be provided with another four weeks supply of Mounjaro to ensure it is clinically appropriate to continue their treatment, he added

In some cases yes, particularly where weight loss has been rapid or substantial